{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-046730","form_type":"8-K","ticker":"GALT","cik":"0001133416","company_name":"GALECTIN THERAPEUTICS INC","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.755040+00:00","generated_at":"2026-05-30T00:15:58.496138+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Galectin Therapeutics posts updated corporate presentation; exhibit truncated, specific content unknown","bullets":["Filed updated corporate presentation on Nov 14, 2024, for use at investor conferences and meetings.","Presentation available on company website; includes forward-looking statements.","Exhibit 99.1 appended but truncated in filing text; no new financial or pipeline details visible.","No specific guidance, trial results, or financing changes disclosed in the filing body."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-046730","json":"https://secwatch.observer/filing/0001140361-24-046730.json","markdown":"https://secwatch.observer/filing/0001140361-24-046730.md","text":"https://secwatch.observer/filing/0001140361-24-046730.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133416/000114036124046730/0001140361-24-046730-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133416/000114036124046730/ef20038323_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:15:58.496138+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}